HY17 Result Presentation
14 February 2017
Chris Smith Chief Executive Officer & President
Neville Mitchell Chief Financial Officer
HY17 - Result highlights
Positive momentum continues across all marketsCochlear implant units 10% (16% excl Chinese Central Government tender)
~10% unit growth across both developed and emerging markets
Sales revenue up 4% (8% in constant currency) with CC growth delivered across all product categories and regions
Strengthened market leadership positionNew products broadening the portfolio - Kanso and CI532
Ongoing investment in market growth initiatives - DTC and sales force expansion
Strong financial positionNet profit 19% to $111.4m
Free cash flow up 50% supports increased dividend and debt reduction
2
FY17 guidance maintained
FY17 net profit guidance maintained at $210-225m, up ~10-20% on FY16 at 75c AUD/USD~10-20%
Adjusted net profit excludes patent dispute provision of $15.8 million after tax in FY14
3
Hearing loss market opportunity
Over 5% of the world's population - 360 million people - has disabling hearing* loss (328 million adults and 32 million children).1 Nearly 1 out of every 3 people over the age of 65 are affected by hearing loss. It affects communication and can contribute to social isolation, anxiety, depression and cognitive decline.2 Market penetration3Who.int. WHO | Deafness and hearing loss [Internet]. 2015
Who.int. WHO | 10 facts on deafness [Internet]. 2015.
Market penetration. This figure is a global estimate based on Cochlear sourced data.
* Disabling hearing loss refers to hearing loss greater than 40 decibels (dB) in the better hearing ear in adults and a hearing loss greater than 30 dB in the better hearing ear in children.
Cochlear's mission
We help people hear and be heard.
We empower people to connect with others and live a full life.
We transform the way people understand and treat hearing loss.
We innovate and bring to market a range of implantable hearing solutions that deliver a lifetime of hearing outcomes.
5
Strategic platforms
Focus on the Customer
Grow the Core Build a Service Business Shape the Organisation Value Creation6
Cochlear implants
Market-leading products and investment in market growth initiatives drive demand Cochlear implant unit growth 10%Unit growth up 16% (excl Chinese Central Govt tender units)
Developed markets up ~10% - continuing strong growth in the US & Western Europe
Emerging markets up ~10% - China Other, India and Central & Eastern Europe
New products launchedSlim Modiolar electrode (CI532) & Kanso sound processor
Initiatives to accelerate market growthDTC & sales force expansion
7
Acoustics
(bone conduction and acoustic implants)
Baha product innovation driving demand and share gains Sales revenue 20% in CCSolid performances across all regions
New products drive sales growthBaha® 5 System made for iPhone
Strong uptake of Baha 5 Power and SuperPower sound processors
CC = constant currency
8
Cochlear Ltd. published this content on 14 February 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 13 February 2017 21:32:07 UTC.
Original documenthttp://coh.live.irmau.com/irm/PDF/1412_0/COHHalfYearResultsAnalystPresentation
Public permalinkhttp://www.publicnow.com/view/BF316F1002B4D53A706379EA4E17F93880A5BFCC